PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,327,767 | -30.1% | 2,017,883 | 0.0% | 0.00% | – |
| Q2 2023 | $1,899,433 | -1.7% | 2,017,883 | 0.0% | 0.00% | – |
| Q1 2023 | $1,932,527 | -30.6% | 2,017,883 | 0.0% | 0.00% | – |
| Q4 2022 | $2,784,679 | +10.5% | 2,017,883 | +0.0% | 0.00% | – |
| Q3 2022 | $2,521,000 | -42.1% | 2,017,050 | +9.4% | 0.00% | – |
| Q2 2022 | $4,351,000 | -19.1% | 1,843,513 | +6.3% | 0.00% | – |
| Q1 2022 | $5,378,000 | -55.8% | 1,734,894 | -9.4% | 0.00% | – |
| Q4 2021 | $12,161,000 | -38.4% | 1,915,086 | -3.4% | 0.00% | – |
| Q3 2021 | $19,751,000 | -20.0% | 1,983,044 | +6.4% | 0.00% | -100.0% |
| Q2 2021 | $24,682,000 | +3.9% | 1,864,133 | +37.2% | 0.00% | 0.0% |
| Q1 2021 | $23,753,000 | -5.9% | 1,358,902 | +37.7% | 0.00% | 0.0% |
| Q4 2020 | $25,233,000 | +271.6% | 986,794 | +90.5% | 0.00% | – |
| Q3 2020 | $6,790,000 | -52.8% | 517,902 | -1.7% | 0.00% | -100.0% |
| Q2 2020 | $14,395,000 | +7853.0% | 526,734 | +4505.5% | 0.00% | – |
| Q1 2020 | $181,000 | – | 11,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |